News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DiaTech Oncology Test Predicts Most Effective Chemotherapy for Cancer Patients



1/15/2013 9:38:05 AM

NASHVILLE, Tenn.--(BUSINESS WIRE)--Published research from a multi-institutional clinical trial shows that physicians frequently use DiaTech Oncology’s customized predictive chemosensitivity test, which is known as the MiCK® assay or CorrectChemo™, when they see an individual patient's results. The test identifies the most effective chemotherapy drug or drug combination to kill a patient’s specific cancer cells.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES